www.afro.who.int

MultiStem Cell Therapy Treatment

Athersys

Category

Laboratory

Country

United States of America (USA), North America

Description

Athersys is to Initiate a Pivotal Clinical Trial Evaluating MultiStem® Cell Therapy in Patients With COVID-19 Induced Acute Respiratory Distress Syndrome

Visit

https://www.athersys.com/investors/press-releases/press-release-details/2020/FDA-Authorizes-Athersys-to-Initiate-a-Pivotal-Clinical-Trial-Evaluating-MultiStem-Cell-Therapy-in-Patients-With-COVID-19-Induced-Acute-Respiratory-Distress-Syndrome/default.aspx